Children in America will be given Covaxin! Ocugen Application for emergency use
New Delhi. Bharat Biotech's US partner Ocugen has informed that it has sought emergency use authorization (EUA) approval for Covaxin for children below 18 years of age from the US Food and Drug Administration (FDA). "We are delighted to announce the EUA filing to the US-Food and Drug Administration (FDA) through our partner-OcuGen," tweeted Dr Ratches Alla, Bharat Biotech's clinical lead for COVID-19 vaccines.
We’ve filed an EUA application with the @US_FDA to seek emergency use authorization of our investigational #COVID-19 vaccine candidate for children ages 2-18 in the US. It is being administered under emergency use authorization in 17 countries. Learn more: https://t.co/DjM7ORsppc pic.twitter.com/DOMKQ2P2YH— Ocugen (@Ocugen) November 5, 2021
The World Health Organization (WHO) on Wednesday approved the Emergency Use List (EUL) for Bharat Biotech's corona vaccine Covaxin. The approval was made on the recommendation of the Technical Advisory Group (TAG) for Emergency Use List (TAG-EUL), an independent advisory panel that provides recommendations to the WHO on whether a COVID-19 vaccine should be considered for emergency use under the EUL process. can be listed.
Bharat Biotech's Covaxin and AstraZeneca and Serum Institute's Covishield are the two most widely used vaccines in India.